Especially, genes targeted by dysregulated miRNAs, such as SMAD4, MAPK1, MYC, TGFBR2, and AKT1, were identified multiple times within these pathways, highlighting their potential importance in the pathophysiology of bone loss in T1D. This evidence concerns the gene MYC and type 1 diabetes mellitus.